These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 27744096)
1. The Efficacy of Postoperative Cyclic Oral Contraceptives after Gonadotropin-Releasing Hormone Agonist Therapy to Prevent Endometrioma Recurrence in Adolescents. Seo JW; Lee DY; Yoon BK; Choi D J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):223-227. PubMed ID: 27744096 [TBL] [Abstract][Full Text] [Related]
2. The age-related recurrence of endometrioma after conservative surgery. Seo JW; Lee DY; Yoon BK; Choi D Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():81-85. PubMed ID: 27894033 [TBL] [Abstract][Full Text] [Related]
3. Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence. Cho S; Jung JA; Lee Y; Kim HY; Seo SK; Choi YS; Lee JS; Lee BS Acta Obstet Gynecol Scand; 2014 Jan; 93(1):38-44. PubMed ID: 24605384 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest. Choi SH; Kim SE; Lim HH; Lee DY; Choi D J Korean Med Sci; 2022 Jul; 37(26):e207. PubMed ID: 35790209 [TBL] [Abstract][Full Text] [Related]
5. Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo. Sesti F; Capozzolo T; Pietropolli A; Marziali M; Bollea MR; Piccione E Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):72-7. PubMed ID: 19665279 [TBL] [Abstract][Full Text] [Related]
6. Postoperative long-term maintenance therapy with oral contraceptives after gonadotropin-releasing hormone analog treatment in women with ovarian endometrioma. Park HJ; Koo YA; Yoon BK; Choi D J Minim Invasive Gynecol; 2009; 16(1):34-9. PubMed ID: 18976968 [TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery. Seo JW; Lee DY; Kim SE; Yoon BK; Choi D Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():53-57. PubMed ID: 30884336 [TBL] [Abstract][Full Text] [Related]
8. Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence. Lee DY; Bae DS; Yoon BK; Choi D Hum Reprod; 2010 Dec; 25(12):3050-4. PubMed ID: 20937741 [TBL] [Abstract][Full Text] [Related]
9. Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study. Chen YJ; Hsu TF; Huang BS; Tsai HW; Chang YH; Wang PH Am J Obstet Gynecol; 2017 Jun; 216(6):582.e1-582.e9. PubMed ID: 28209488 [TBL] [Abstract][Full Text] [Related]
10. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Seracchioli R; Mabrouk M; Frascà C; Manuzzi L; Montanari G; Keramyda A; Venturoli S Fertil Steril; 2010 Jan; 93(1):52-6. PubMed ID: 18973896 [TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference? Cucinella G; Granese R; Calagna G; Svelato A; Saitta S; Tonni G; De Franciscis P; Colacurci N; Perino A Arch Gynecol Obstet; 2013 Oct; 288(4):821-7. PubMed ID: 23580011 [TBL] [Abstract][Full Text] [Related]
12. Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial. Muzii L; Marana R; Caruana P; Catalano GF; Margutti F; Panici PB Am J Obstet Gynecol; 2000 Sep; 183(3):588-92. PubMed ID: 10992178 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence. Kim ML; Cho YJ; Kim MK; Jung YW; Yun BS; Seong SJ Int J Gynaecol Obstet; 2016 Sep; 134(3):256-9. PubMed ID: 27346551 [TBL] [Abstract][Full Text] [Related]
14. Recurrence of Ovarian Endometrioma in Adolescents after Conservative, Laparoscopic Cyst Enucleation. Lee SY; Kim ML; Seong SJ; Bae JW; Cho YJ J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):228-233. PubMed ID: 26612115 [TBL] [Abstract][Full Text] [Related]
15. [Short-term outcome of leuprorelin acetate in preventing recurrence of ovarian endometrioma after conservative surgery]. Yuan L; Wu QJ; Liu XS Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):508-10. PubMed ID: 24284221 [TBL] [Abstract][Full Text] [Related]
16. Preventive therapeutic options for postoperative recurrence of ovarian endometrioma: gonadotropin-releasing hormone agonist with or without levonorgestrel intrauterine system insertion. Zhu SY; Wu YS; Gu ZY; Zhang J; Jia SZ; Shi JH; Dai Y; Leng JH; Li XY Arch Gynecol Obstet; 2021 Feb; 303(2):533-539. PubMed ID: 33104866 [TBL] [Abstract][Full Text] [Related]
17. Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery. Jee BC; Lee JY; Suh CS; Kim SH; Choi YM; Moon SY Fertil Steril; 2009 Jan; 91(1):40-5. PubMed ID: 18377899 [TBL] [Abstract][Full Text] [Related]
18. Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis. Vercellini P; DE Matteis S; Somigliana E; Buggio L; Frattaruolo MP; Fedele L Acta Obstet Gynecol Scand; 2013 Jan; 92(1):8-16. PubMed ID: 22646295 [TBL] [Abstract][Full Text] [Related]
19. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis. Muzii L; Di Tucci C; Achilli C; Di Donato V; Musella A; Palaia I; Panici PB Am J Obstet Gynecol; 2016 Feb; 214(2):203-211. PubMed ID: 26364832 [TBL] [Abstract][Full Text] [Related]
20. Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study. Kim MK; Chon SJ; Lee JH; Yun BH; Cho S; Choi YS; Lee BS; Seo SK Reprod Sci; 2018 Jan; 25(1):39-43. PubMed ID: 28683602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]